Related references
Note: Only part of the references are listed.Natural products may interfere with SARS-CoV-2 attachment to the host cell
Abdo A. Elfiky
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies
Simin Seyedpour et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
N- and O-Glycosylation of the SARS-CoV-2 Spike Protein
Miloslav Sanda et al.
ANALYTICAL CHEMISTRY (2021)
Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable Targets
Isabella Romeo et al.
MOLECULES (2021)
Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
Goran Kokic et al.
NATURE COMMUNICATIONS (2021)
Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021
Summer E. Galloway et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
SARS-CoV-2 Vaccines
C. Buddy Creech et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
High-dose intravenous vitamin C attenuates hyperinflammation in severe coronavirus disease 2019
Guozhi Xia et al.
NUTRITION (2021)
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Dami A. Collier et al.
NATURE (2021)
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
Constantinos Kurt Wibmer et al.
NATURE MEDICINE (2021)
Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro
Martina Morokutti-Kurz et al.
PLOS ONE (2021)
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Nicholas G. Davies et al.
SCIENCE (2021)
Detection of B.1.351 SARS-CoV-2 Variant Strain - Zambia, December 2020
Mulenga Mwenda et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention
Alessio Danilo Inchingolo et al.
MICROORGANISMS (2021)
Molecular Mechanisms Behind Anti SARS-CoV-2 Action of Lactoferrin
Mattia Miotto et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization
Pengfei Wang et al.
CELL HOST & MICROBE (2021)
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
Erik Volz et al.
NATURE (2021)
Human coronavirus spike protein-host receptor recognition
Lalitha Guruprasad
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2021)
Quinine Inhibits Infection of Human Cell Lines with SARS-CoV-2
Maximilian Grosse et al.
VIRUSES-BASEL (2021)
The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus
Yeong Jun Kim et al.
VIRUSES-BASEL (2021)
Griffithsin and Carrageenan Combination Results in Antiviral Synergy against SARS-CoV-1 and 2 in a Pseudoviral Model
Sahar Alsaidi et al.
MARINE DRUGS (2021)
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
Delphine Planas et al.
NATURE (2021)
Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
Matthias Becker et al.
NATURE COMMUNICATIONS (2021)
SARS-CoV-2 spike E484K mutation reduces antibody neutralisation
Sonia Jangra et al.
LANCET MICROBE (2021)
Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study
Li Guo et al.
EMERGING MICROBES & INFECTIONS (2021)
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Victor M. Corman et al.
EUROSURVEILLANCE (2020)
Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19)
Fang Jiang et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2020)
Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
Yushun Wan et al.
JOURNAL OF VIROLOGY (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Site-specific glycan analysis of the SARS-CoV-2 spike
Yasunori Watanabe et al.
SCIENCE (2020)
COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis
Long-quan Li et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
Xiuyuan Ou et al.
NATURE COMMUNICATIONS (2020)
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Jia Liu et al.
CELL DISCOVERY (2020)
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Bette Korber et al.
CELL (2020)
Turning the Tide: Natural Products and Natural-Product-Inspired Chemicals as Potential Counters to SARS-CoV-2 Infection
Zhonglei Wang et al.
FRONTIERS IN PHARMACOLOGY (2020)
Natural product-derived phytochemicals as potential agents against coronaviruses: A review
Janice S. Mani et al.
VIRUS RESEARCH (2020)
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
Peter Horby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A novel method for live imaging of human airway cilia using wheat germ agglutinin
Ryosuke Nakamura et al.
SCIENTIFIC REPORTS (2020)
Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers
Anshul Jain et al.
SCIENTIFIC REPORTS (2020)
Human coronaviruses OC43 and HKU1 bind to 9-O-acetylated sialic acids via a conserved receptor-binding site in spike protein domain A
Ruben J. G. Hulswit et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Wheat Germ Agglutinin as a Potential Therapeutic Agent for Leukemia
Bradley Ryva et al.
FRONTIERS IN ONCOLOGY (2019)
Plant Foods, Antioxidant Biomarkers, and the Risk of Cardiovascular Disease, Cancer, and Mortality: A Review of the Evidence
Dagfinn Aune
ADVANCES IN NUTRITION (2019)
Human coronavirus circulation in the United States 2014-2017
Marie E. Killerby et al.
JOURNAL OF CLINICAL VIROLOGY (2018)
Development of a nasal spray containing xylometazoline hydrochloride and iota-carrageenan for the symptomatic relief of nasal congestion caused by rhinitis and sinusitis
Christine Graf et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2018)
Amylmetacresol/2,4-dichlorobenzyl alcohol, hexylresorcinol, or carrageenan lozenges as active treatments for sore throat
Martina Morokutti-Kurz et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2017)
Wheat germ agglutinin and Lens culinaris agglutinin sensitized anisotropic silver nanoparticles in detection of bacteria: A simple photometric assay
Mariam V. Mikaelyan et al.
ANALYTICA CHIMICA ACTA (2017)
Antiviral lectins: Selective inhibitors of viral entry
Carter A. Mitchell et al.
ANTIVIRAL RESEARCH (2017)
Wheat germ agglutinin staining as a suitable method for detection and quantification of fibrosis in cardiac tissue after myocardial infarction
B. Emde et al.
EUROPEAN JOURNAL OF HISTOCHEMISTRY (2014)
Antiviral Lectins from Red and Blue-Green Algae Show Potent In Vitro and In Vivo Activity against Hepatitis C Virus
Yutaka Takebe et al.
PLOS ONE (2013)
Wheat germ agglutinin-conjugated PLGA nanoparticles for enhanced intracellular delivery of paclitaxel to colon cancer cells
Chunxia Wang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae
Barry R. O'Keefe et al.
JOURNAL OF VIROLOGY (2010)
A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo
Craig W. Day et al.
VIROLOGY (2009)
Phase I trial of r viscumin (INN: aviscumine) given subcutaneously in patients with advanced cancer:: A study of the European Organisation for Research and Treatment of Cancer (EORTC protocol number 13001)
Lothar Bergmann et al.
EUROPEAN JOURNAL OF CANCER (2008)
Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle
Els Keyaerts et al.
ANTIVIRAL RESEARCH (2007)
Dissecting carbohydrate-Cyanovirin-N binding by structure-guided mutagenesis: functional implications for viral entry inhibition
Laura G. Barrientos et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2006)
WGA-grafted PLGA-nano spheres:: preparation and association with Caco-2 single cells
A Weissenböck et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China
Z Zhao et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2003)
Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus
LG Barrientos et al.
ANTIVIRAL RESEARCH (2003)
Analysis of the interaction between the HIV-Inactivating protein cyanovirin-N and soluble forms of the envelope glycoproteins gp120 and gp41
BR O'Keefe et al.
MOLECULAR PHARMACOLOGY (2000)
Effects of lectins with different carbohydrate-binding specificities on hepatoma, choriocarcinoma, melanoma and osteosarcoma cell lines
HX Wang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2000)